It’s national hereditary breast & ovarian cancer week.
Are you ensuring that all patients who qualify for genetic testing get it?

• An estimated 1.2 to 1.3 million women in the US with breast or ovarian cancer who qualified for genetic testing failed to receive it¹
• More than 85% of patients with breast cancer and 80% of patients with ovarian cancer never even discussed genetic testing with their physician¹  
• Yet testing can uncover actionable findings, leading to a significant change in clinical management^2,3

Invitae makes genetic testing easy:

	Consult with experts Call board-certified genetic counselors on-demand to review patient cases, differentiate between test options, and aid in interpreting results
	Genetic counseling Patients can consult with a genetic counselor at no additional charge, including comprehensive post-test counseling sessions
	CancerCHECK A simple and secure tool helps identify patients appropriate for testing using an automated survey, choose the appropriate test, and more

Request our collection kit to get started.

References
1. Childers CP et al. National estimates of genetic testing in women with a history of breast or ovarian cancer. JCO. 2017 Aug 18. [Epub ahead of print]
2. Yadav S. et al. Outcomes of retesting BRCA negative patients using multigene panels. Fam Cancer. 2017 Jul;16(3):319-328.
3. Lincoln SE et al. A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients. J Mol Diagn. 2015 Sep;17(5):533-44.